Diagnostic options · UAE

Genetics tests in Dubai & UAE

Compare available Genetics tests, their listed prices and the information provided for each option. Test selection and preparation should be discussed with your clinician.

Tests in this category

2,789

Listed price range

-1.00–50,000.00 AED

Clinical preparation

Confirm test-specific instructions with your clinician or laboratory.

Compare available tests

Genetics test prices

Showing 2416–2430 of 2,789 matching tests.

Genetics diagnostic tests, details, and listed prices
Test and description	Specimen	Typical duration	Price	Options
TEST-3372 SPATA16 Gene (SPGF6) Genetic Test This test identifies pathogenic mutations in the SPATA16 gene associated with spermatogenic failure type 6 (SPGF6), a cause of male infertility.	Peripheral whole blood (EDTA)	21–28 business days	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic mutations in the SPATA16 gene", "Spermatogenic failure type 6 (SPGF6)"] Parameters [] Preparation ["Mandatory pre-test genetic counseling session", "Provide peripheral blood sample via standard venipuncture"] Indications ["Diagnosis of spermatogenic failure type 6 (SPGF6)", "Evaluation of male infertility", "Guidance for assisted reproductive technologies"] Measurement technique Confirm with laboratory Codes LOINC: 21636-6 ICD-10: N46.0, N46.1 Clinical summary This test identifies pathogenic mutations in the SPATA16 gene associated with spermatogenic failure type 6 (SPGF6), a cause of male infertility.
TEST-4356 SPATA5 Gene Epilepsy, Hearing Loss, and Mental Retardation Syndrome Genetic Test This genetic test evaluates the SPATA5 gene for mutations associated with epilepsy, hearing loss, and intellectual disability.	Peripheral whole blood (EDTA), extracted genomic DNA, or dried blood spot (FTA card)	3 – 4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["SPATA5 gene sequence", "Pathogenic variants in SPATA5"] Parameters [] Preparation ["No specific fasting required", "Inform lab of any anticoagulant medication"] Indications ["Suspected SPATA5-related disorder", "Family history of SPATA5-related disorder", "Unexplained epilepsy, hearing loss, and intellectual disability"] Measurement technique Confirm with laboratory Codes LOINC: 81247-9 ICD-10: Q87.8, G40.9, H90.3, F70 Clinical summary This genetic test evaluates the SPATA5 gene for mutations associated with epilepsy, hearing loss, and intellectual disability.
TEST-4006 SPEG Gene Centronuclear Myopathy Type 5 Genetic Test This test evaluates the SPEG gene for pathogenic variants associated with centronuclear myopathy type 5.	Peripheral Whole Blood (EDTA)	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the SPEG gene", "Single nucleotide variants (SNVs)", "Insertions and deletions (indels)", "Copy number variations (CNVs)"] Parameters [] Preparation [] Indications ["Clinical suspicion of congenital myopathy with central nuclei", "Definitive diagnosis", "Prognosis", "Informed family planning"] Measurement technique Confirm with laboratory Codes LOINC: 81260-0 ICD-10: G71.2 Clinical summary This test evaluates the SPEG gene for pathogenic variants associated with centronuclear myopathy type 5.
TEST-5625 SPG11 Gene Sequencing (NGS) Test This test analyzes the SPG11 gene for mutations associated with Hereditary Spastic Paraplegia Type 11 (HSP-11).	Whole Blood, Extracted DNA, Dried Blood Spot (FTA Card)	10–14 business days	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the SPG11 gene", "Coding regions of the SPG11 gene"] Parameters [] Preparation [] Indications ["Suspected Hereditary Spastic Paraplegia Type 11 (HSP-11)", "Progressive lower limb spasticity and weakness", "Family history of HSP-11"] Measurement technique Confirm with laboratory Codes LOINC: 40825-5 ICD-10: G11.4 Clinical summary This test analyzes the SPG11 gene for mutations associated with Hereditary Spastic Paraplegia Type 11 (HSP-11).
TEST-5642 SPG21 Gene Genetic Test This test evaluates the SPG21 gene for pathogenic variants associated with Autosomal Recessive Spastic Paraplegia type 21.	Peripheral Blood	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the SPG21 gene"] Parameters [] Preparation ["Do not discontinue prescribed medication without consulting your doctor"] Indications ["Individuals with progressive lower limb spasticity or gait disturbance", "Family history of autosomal recessive spastic paraplegia", "Unexplained stiffness and weakness in the legs", "Asymptomatic carriers assessing reproductive risks"] Measurement technique Confirm with laboratory Codes LOINC: 81247-9 ICD-10: G11.4 Clinical summary This test evaluates the SPG21 gene for pathogenic variants associated with Autosomal Recessive Spastic Paraplegia type 21.
TEST-5694 SPG60 (WDR48 Gene) Genetic Test This test evaluates the WDR48 gene for pathogenic variants associated with autosomal recessive hereditary spastic paraplegia type 60 (SPG60). It detects single nucleotide variants,...	Whole Blood (peripheral)	3 to 4 Weeks	-1.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["WDR48 gene variants", "Single nucleotide variants", "Small insertions/deletions", "Copy number variations"] Parameters [] Preparation ["No specific fasting required", "Standard whole blood specimen"] Indications ["Suspected hereditary spastic paraplegia type 60", "Family history of SPG60", "Carrier screening", "Family planning"] Measurement technique Confirm with laboratory Codes LOINC: 87808-4 ICD-10: G11.4 Clinical summary This test evaluates the WDR48 gene for pathogenic variants associated with autosomal recessive hereditary spastic paraplegia type 60 (SPG60). It detects single nucleotide variants, small insertions/deletions, and copy number variations.
TEST-5809 SPG7 Gene Genetic Test This test analyzes the SPG7 gene for pathogenic variants associated with Hereditary Spastic Paraplegia type 7.	Whole blood (EDTA)	3–4 weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the SPG7 gene", "Single-nucleotide variants", "Small indels", "Copy-number changes"] Parameters [] Preparation ["No specific fasting required", "Do not discontinue prescribed medication"] Indications ["Suspicion of Hereditary Spastic Paraplegia type 7", "Diagnosis of progressive spastic-ataxic disorders", "Genetic counselling for affected families"] Measurement technique Confirm with laboratory Codes LOINC: 55233-1 ICD-10: G11.4 Clinical summary This test analyzes the SPG7 gene for pathogenic variants associated with Hereditary Spastic Paraplegia type 7.
TEST-5900 Sphingolipidosis Enzyme Panel (Genetic Test) This genetic test evaluates for pathogenic variants in genes associated with sphingolipid storage diseases.	Whole blood (EDTA) or dried blood spot (FTA card)	21–28 Days	3,000.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in genes like GBA, SMPD1, GLA", "Point mutations", "Small indels", "Large deletions/duplications", "Copy number variants"] Parameters [] Preparation ["Attend mandatory pre-test genetic counseling", "Provide detailed family pedigree", "No fasting required", "Be in good health without acute infection", "Bring relevant medical records and medication list"] Indications ["Diagnosis of suspected sphingolipidosis", "Carrier screening", "Prenatal diagnosis", "Preimplantation genetic diagnosis (PGD)", "Family planning"] Measurement technique Confirm with laboratory Codes LOINC: 103213-3 ICD-10: E75.2, Z13.228, Z84.81 Clinical summary This genetic test evaluates for pathogenic variants in genes associated with sphingolipid storage diseases.
TEST-1097 Spinal Muscular Atrophy (SMA) Gene Panel Test This test evaluates the SMN1 and SMN2 genes for pathogenic variants associated with Spinal Muscular Atrophy (SMA).	Amniotic Fluid, Chorionic Villi, Peripheral Blood	4–6 weeks	4,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["SMN1 gene variants", "SMN2 gene variants", "Copy number variations (deletions/duplications)"] Parameters [] Preparation [] Indications ["Confirmatory diagnosis of SMA", "Carrier screening", "Prenatal diagnosis"] Measurement technique Confirm with laboratory Codes LOINC: 92661-8 ICD-10: G12.9 Clinical summary This test evaluates the SMN1 and SMN2 genes for pathogenic variants associated with Spinal Muscular Atrophy (SMA).
TEST-1100 Spinal Muscular Atrophy Carrier Screening Test This test detects deletions or duplications in the SMN1 gene, identifying individuals who are carriers for Spinal Muscular Atrophy.	Peripheral whole blood (EDTA or ACD tube)	7–10 days	1,500.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["SMN1 gene copy number", "SMN2 gene copy number"] Parameters [{"name": "SMN1 Copy Number", "reference_range": "Typically 2 copies (normal); 1 copy (carrier); 0 copies (affected)"}, {"name": "SMN2 Copy Number", "reference_range": "Variable, typically 2-4 copies"}] Preparation ["No fasting required", "No special preparation needed", "Ensure adequate hydration"] Indications ["Family planning", "Pre-conception screening", "Individuals with a family history of SMA"] Measurement technique Confirm with laboratory Codes LOINC: 81314-9 ICD-10: Z13.89 Clinical summary This test detects deletions or duplications in the SMN1 gene, identifying individuals who are carriers for Spinal Muscular Atrophy.
TEST-4759 SPINK5 Gene Netherton Syndrome Genetic Test This genetic test evaluates the SPINK5 gene for pathogenic variants associated with Netherton syndrome.	Whole Blood (EDTA, 3–5 mL), Extracted DNA, or FTA Card Dried Blood Spot	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the SPINK5 gene", "Copy Number Variations (CNVs) in the SPINK5 gene"] Parameters [] Preparation [] Indications ["Clinical suspicion of Netherton syndrome", "Family history of Netherton syndrome", "Confirmation of diagnosis in individuals with characteristic features"] Measurement technique Confirm with laboratory Codes LOINC: 95135-6 ICD-10: Q80.4 Clinical summary This genetic test evaluates the SPINK5 gene for pathogenic variants associated with Netherton syndrome.
TEST-3154 Spino‑Bulbar Muscular Atrophy (SBMA) Genetic Test This test evaluates the androgen receptor (AR) gene for CAG repeat expansions, which are characteristic of Spino-Bulbar Muscular Atrophy (Kennedy disease).	Whole Blood (EDTA)	5 Working Days	1,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["CAG repeat expansion in the AR gene", "Number of CAG repeats"] Parameters [{"name": "CAG Repeat Number", "reference_range": "Normal: Preparation ["No specific fasting required", "Inform phlebotomist of any known bleeding disorders"] Indications ["Suspected Kennedy disease based on clinical presentation", "Family history of Kennedy disease", "Cascade family screening"] Measurement technique Confirm with laboratory Codes LOINC: 21666-9 ICD-10: G12.21 Clinical summary This test evaluates the androgen receptor (AR) gene for CAG repeat expansions, which are characteristic of Spino-Bulbar Muscular Atrophy (Kennedy disease).
TEST-3090 Spinocerebellar Ataxia Type 12 (SCA12) PPP2R2B Gene Mutation Test This test identifies the specific CAG trinucleotide repeat expansion in the PPP2R2B gene, confirming or excluding a diagnosis of Spinocerebellar Ataxia Type 12.	Whole Blood (4 mL Lavender-top EDTA tube)	10–12 Business Days	750.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["CAG trinucleotide repeat expansion", "PPP2R2B gene sequence"] Parameters [{"name": "CAG Repeat Length", "reference_range": " Preparation ["Remain well-hydrated", "Maintain regular diet unless instructed otherwise", "Ensure Genomics Clinical Information Requisition Form (Form 20) is filled and signed"] Indications ["Suspected Spinocerebellar Ataxia Type 12", "Familial risk assessment for SCA12"] Measurement technique Confirm with laboratory Codes LOINC: 83746-8 ICD-10: G11.2 Clinical summary This test identifies the specific CAG trinucleotide repeat expansion in the PPP2R2B gene, confirming or excluding a diagnosis of Spinocerebellar Ataxia Type 12.
TEST-3105 Spinocerebellar Ataxia Type 7 (SCA7) ATXN7 Gene Mutation Test This test detects pathogenic CAG trinucleotide repeat expansions in the ATXN7 gene, confirming a diagnosis of Spinocerebellar Ataxia Type 7.	Whole blood	5 working days (Sample by Tuesday 11 am → Report Saturday)	750.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["CAG trinucleotide repeat expansion length in the ATXN7 gene"] Parameters [{"name": "CAG Repeat Length", "reference_range": "4–17 repeats (Wild-type)"}] Preparation [] Indications ["Symptomatic individuals suspected of having Spinocerebellar Ataxia Type 7", "Differential diagnosis of progressive ataxia", "Assessment of hereditary risk for family members"] Measurement technique Confirm with laboratory Codes LOINC: 78000-9 ICD-10: G11.8, Z13.71, Z84.8 Clinical summary This test detects pathogenic CAG trinucleotide repeat expansions in the ATXN7 gene, confirming a diagnosis of Spinocerebellar Ataxia Type 7.
TEST-6339 SPINT2 Gene Sequencing Test This test evaluates the SPINT2 gene for pathogenic variants associated with congenital sodium diarrhea, syndromic type 3.	Whole Blood, Extracted DNA, or FTA Card	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the SPINT2 gene", "Full coding exons + splice junctions"] Parameters [] Preparation ["No specific fasting required", "Inform lab of any current medications"] Indications ["Diagnosis of congenital sodium diarrhea, syndromic type 3", "Carrier screening", "Guided family planning"] Measurement technique Confirm with laboratory Codes LOINC: 81308-0 ICD-10: P78.3 Clinical summary This test evaluates the SPINT2 gene for pathogenic variants associated with congenital sodium diarrhea, syndromic type 3.

Category overview

Genetics: overview

Understanding your unique biological blueprint offers a profound sense of clarity and empowers proactive health planning for you and your family. At DNA Labs UAE, our specialized Genetics division employs state-of-the-art molecular technologies to provide deep insights into hereditary markers and cellular mutations. This comprehensive genetics testing in the UAE equips your healthcare provider with the precise data needed to tailor your medical guidance effectively. Recognized among top diagnostic labs in Dubai and the UAE, we prioritize your peace of mind through strict confidentiality protocols and exceptionally fast, accurate reporting. Take the next step in your health journey. View our genetics diagnostic services, book a private home collection, or consult our specialized team today.

Before booking

Use the test details as a conversation starter

The right diagnostic option depends on your reason for testing and individual circumstances. Check the listed specimen and timing, then confirm any preparation requirements with the ordering clinician or laboratory before collection.

Explore this area

Genetics tests in Dubai & UAE

Genetics test prices

Genetics: overview

Use the test details as a conversation starter

Related Genetics categories